Loading
institutionsInstitution
Renji Hospital, Shanghai Jiao Tong University
Renji Hospital and the Shanghai Cancer Institute on its campus are where CARsgen's solid-tumour CAR-T work began, including the Claudin 18.2 CAR-T satri-cel for stomach cancer.
Also called: Renji Hospital仁济医院Shanghai Cancer Institute
Overview
Home of the State Key Laboratory of Oncogenes and Related Genes (Shanghai Cancer Institute), where Li Zonghai developed GPC3 and Claudin 18.2 CAR-T cells before founding CARsgen; a large gastrointestinal oncology and liver programme and one of the first sites for CT041 (satricabtagene autoleucel) trials.
Location
Shanghai, CN
Type
hospital · Shanghai Jiao Tong University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#424 · 12 points (0 Newsweek + 0 NCI + 12 from 6 linked objects) · ranking
- Shanghai Cancer Institute
- Solid tumour CAR-T trials
- Gastrointestinal oncology
Similar pages
- TrialLUMMICAR STUDY 1
Shares Zevorcabtagene autoleucel, CARsgen Therapeutics, CAR-T cell therapy and the tag china.
- TrialCT041-ST-01
Shares CARsgen Therapeutics, Satricabtagene autoleucel, CAR-T cell therapy, Gastric & gastro-oesophageal junction cancer and the tag china.
- Key paperClaudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
Shares CARsgen Therapeutics, Satricabtagene autoleucel, CAR-T cell therapy, Gastric & gastro-oesophageal junction cancer and the tag china.
- InstitutionJiangsu Cancer Hospital
Shares Gastric & gastro-oesophageal junction cancer and the tag china.
- CompanyIASO Biotherapeutics
Shares CAR-T cell therapy and the tag china.
- PersonJianming Xu
Shares Gastric & gastro-oesophageal junction cancer and the tag china.
- InstitutionPeking University People's Hospital
Shares CAR-T cell therapy and the tag china.
- InstitutionInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Shares CAR-T cell therapy and the tag china.
cancers
technologies
drugs
ApprovedCAR-T (Claudin 18.2)
ApprovedCell therapy (autologous BCMA CAR-T, fully human binder)
Zevorcabtagene autoleucel · Saikaize